Triomics, a startup building an AI-powered platform to help oncologists and administrative staff automate data-heavy tasks like clinical trial matching and appointment prep, has raised $22 million in Series B funding.
The round was led by Battery Ventures, with participation from returning backers Nexus Venture Partners, Lightspeed, Y Combinator, and others.
Originally reported by TechCrunch
CommentLoaderSave StorySave this storyCommentLoaderSave StorySave this storyA Google security engineer has been charged ...
Rivian has finally revealed that the first customers of the company’s new R2 SUV will get their vehicles on June 9...
California civil rights agency hails win over Tesla, anticipates trial in July.
Telltale SSD activity can be measured in the browser using simple JavaScript.